ClinConnect ClinConnect Logo
Search / Trial NCT06479122

Efficacy of Acetaminophen Alone Versus Combination of Acetaminophen/Ibuprofen After Cesarean Section

Launched by SEOUL NATIONAL UNIVERSITY HOSPITAL · Jun 24, 2024

Trial Information

Current as of July 22, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how effective different pain relief methods are after a cesarean section (a surgical procedure to deliver a baby). Specifically, it will compare the use of intravenous acetaminophen alone with a combination of acetaminophen and ibuprofen (a common over-the-counter pain reliever). The goal is to find out which method provides better pain relief for women recovering from this surgery.

To participate in this trial, women must be scheduled for an elective cesarean section and be at least 37 weeks pregnant. However, some women will not be eligible, including those having emergency cesarean sections, those who are pregnant with multiples (like twins), or those with certain medical conditions such as liver or kidney disease. If eligible, participants will receive one of the two pain relief methods after their surgery and will help researchers learn more about managing pain effectively after cesarean deliveries.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Patients scheduled for elective cesarean section
  • Gestational age \> 37+0 weeks
  • Exclusion Criteria:
  • Emergency cesarean section
  • Multiple pregnancy (e.g. twins, triplets)
  • Body weight \< 50 kg
  • Preeclampsia
  • History of hypersensitivity to acetaminophen or ibuprofen
  • History of upper gastrointestinal tract bleeding or gastric ulcer
  • Underlying liver disease
  • Underlying kidney disease or GFR \< 90 mL/min/1.73m2
  • Heart failure or severe hypertension
  • History of asthma
  • Chronic use of barbital or tricyclic antidepressants

About Seoul National University Hospital

Seoul National University Hospital (SNUH) is a leading medical institution in South Korea, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, SNUH integrates cutting-edge scientific inquiry with patient-centered care, facilitating the development of novel therapies and treatment protocols. The hospital boasts a diverse range of specialized departments and a robust infrastructure for conducting clinical studies, ensuring rigorous adherence to ethical standards and regulatory compliance. By fostering collaboration among multidisciplinary teams, SNUH aims to contribute significantly to global medical advancements and improve patient outcomes.

Locations

Seoul, , Korea, Republic Of

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported